ID

21388

Description

NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: ABC-Containing Product Discontinuation Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Mots-clés

Versions (1)
  1. 19/04/2017 19/04/2017 -
Téléchargé le

19 avril 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Genetic Screening For HLA-B*5701 in Patients with HIV ABC-Containing Product Discontinuation NCT00340080

Anglais

Genetic Screening For HLA-B*5701 ABC-Containing Product Discontinuation NCT00340080

1 Formulaires  
ABC-Containing Product Discontinuation
Description

ABC-Containing Product Discontinuation

Alias
UMLS CUI-1
C0013227
UMLS CUI-2
C0663655
UMLS CUI-3
C0850893
Subject Identifier
Description

Subject Identifier

Type de données

text

Alias
UMLS CUI [1]
C2348585
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Ziagen:
Description

Ziagen stopped

Type de données

text

Alias
UMLS CUI [1,1]
C0724476
UMLS CUI [1,2]
C0850893
Primary reason the ABC-Containing Product was stopped, Ziagen:
Description

If Yes, 􏰀check the primary reason the ABC-Containing Product was stopped

Type de données

integer

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0724476
Primary reason the ABC-Containing Product was stopped, Ziagen:
Description

If Other, please specify

Type de données

text

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0724476
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Trizivir:
Description

Trizivir stopped

Type de données

text

Alias
UMLS CUI [1,1]
C0939514
UMLS CUI [1,2]
C0850893
Primary reason the ABC-Containing Product was stopped, Trizivir:
Description

primary reason Trizivir was stopped

Type de données

integer

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0939514
Primary reason the ABC-Containing Product was stopped, Trizivir:
Description

If Other, please specify

Type de données

text

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0939514
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Kivexa:
Description

Kivexa stopped

Type de données

text

Alias
UMLS CUI [1,1]
C1567988
UMLS CUI [1,2]
C0850893
Primary reason the ABC-Containing Product was stopped, Kivexa:
Description

primary reason Kivexa was stopped

Type de données

integer

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C1567988
Primary reason the ABC-Containing Product was stopped, Kivexa:
Description

If Other, please specify

Type de données

text

Alias
UMLS CUI [1,1]
C0850893
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C1567988
Retour au début de la page

Similar models

Genetic Screening For HLA-B*5701 ABC-Containing Product Discontinuation NCT00340080

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
ABC-Containing Product Discontinuation
C0013227 (UMLS CUI-1)
C0663655 (UMLS CUI-2)
C0850893 (UMLS CUI-3)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Ziagen:
text
C0724476 (UMLS CUI [1,1])
C0850893 (UMLS CUI [1,2])
ABC-Containing product stopped
Code List
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Ziagen:
CL Item
Yes (Y)
CL Item
No (N)
Item
Primary reason the ABC-Containing Product was stopped, Ziagen:
integer
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
primary reason the ABC-Containing Product was stopped
Code List
Primary reason the ABC-Containing Product was stopped, Ziagen:
CL Item
Adverse event (Record details on the Non-Serious Adverse Events or Serious Adverse Event (1)
CL Item
Lost to follow-up (2)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Investigator Decision (26)
CL Item
Other, specify (0)
primary reason Ziagen was stopped
Item
Primary reason the ABC-Containing Product was stopped, Ziagen:
text
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0724476 (UMLS CUI [1,3])
Item
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Trizivir:
text
C0939514 (UMLS CUI [1,1])
C0850893 (UMLS CUI [1,2])
ABC-Containing product stopped
Code List
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Trizivir:
CL Item
Yes (Y)
CL Item
No (N)
Item
Primary reason the ABC-Containing Product was stopped, Trizivir:
integer
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
primary reason the ABC-Containing Product was stopped
Code List
Primary reason the ABC-Containing Product was stopped, Trizivir:
CL Item
Adverse event (Record details on the Non-Serious Adverse Events or Serious Adverse Event (1)
CL Item
Lost to follow-up (2)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Investigator Decision (26)
CL Item
Other, specify (0)
primary reason Trizivir was stopped
Item
Primary reason the ABC-Containing Product was stopped, Trizivir:
text
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0939514 (UMLS CUI [1,3])
Item
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Kivexa:
text
C1567988 (UMLS CUI [1,1])
C0850893 (UMLS CUI [1,2])
ABC-Containing product stopped
Code List
Was the ABC-Containing product stopped permanently before the end of the scheduled treatment period? Kivexa:
CL Item
Yes (Y)
CL Item
No (N)
Item
Primary reason the ABC-Containing Product was stopped, Kivexa:
integer
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])
primary reason the ABC-Containing Product was stopped
Code List
Primary reason the ABC-Containing Product was stopped, Kivexa:
CL Item
Adverse event (Record details on the Non-Serious Adverse Events or Serious Adverse Event (1)
CL Item
Lost to follow-up (2)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Lack of efficacy (5)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Investigator Decision (26)
CL Item
Other, specify (0)
primary reason Kivexa was stopped
Item
Primary reason the ABC-Containing Product was stopped, Kivexa:
text
C0850893 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C1567988 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial